RE: l2?1 Jul 2020 16:05
OlderandWiser,
Its not fair of me to knock another stock on this forum, you can print this statement out and keep it for reference. AVCT is massively over hyped. Covid aside more of their tech is pre clinical. Please research how long it takes for anything to move from preclinical to phase I and Phase II, thereafter you have Phase III and approvals. It takes years and years with millions of pounds of investment to make it.
A comparable example, Tils have a drug Miciclib, which took 3 years to get to Phase II from Phase I. Dont be fooled by the hype. If, and i mean a massive IF, they somehow get a drug into market (remember FDA approval is around 13% success rate - ill also mention if they fail FDA your SP will be scraping the barrel thats how fast itll fall) then you will see £5, and you will be waiting many years for that.
The fact that most of their treatments are not in Phase I or Phase II, its an incredible risk. Let me also say, IF the tech was a one in a lifetime opportunity, the big boys are not stupid, the money they spend on R&D in 1 year would buy out the whole of AVCT.
For a covid play AVCT is fine, if it pulls off. For the cancer drugs i would advise you to stay well away.